Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy

Autor: Kerioui, M., Desmée, S., Mercier, F., Lin, A., Wu, B., Jin, J.Y., Shen, X., Le Tourneau, C., Bruno, R., Guedj, J.
Zdroj: In ESMO Open February 2022 7(1)
Databáze: ScienceDirect